Concord Medical Services Holdings (NYSE:CCM) — Market Cap & Net Worth
Market Cap & Net Worth: Concord Medical Services Holdings (CCM)
Concord Medical Services Holdings (NYSE:CCM) has a market capitalization of $13.68 Million ($13.68 Million) as of August 6, 2026. Listed on the NYSE stock exchange, this USA-based company holds position #26233 globally and #5420 in its home market, demonstrating a 5.65% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Concord Medical Services Holdings's stock price $4.86 by its total outstanding shares 2815458 (2.82 Million). See Concord Medical Services Holdings (CCM) capital reinvestment to understand how much of operating cash flow is reinvested back into capital assets.
Concord Medical Services Holdings Market Cap History: 2015 to 2026
Concord Medical Services Holdings's market capitalization history from 2015 to 2026. Data shows change from $136.27 Million to $13.68 Million (-18.34% CAGR).
Concord Medical Services Holdings Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Concord Medical Services Holdings's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.02x
Concord Medical Services Holdings's market cap is 0.02 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $129.51 Million | $455.04 Million | -$261.87 Million | 0.28x | N/A |
| 2017 | $93.75 Million | $330.98 Million | -$284.32 Million | 0.28x | N/A |
| 2018 | $100.23 Million | $190.90 Million | -$234.88 Million | 0.53x | N/A |
| 2019 | $75.17 Million | $198.36 Million | -$307.05 Million | 0.38x | N/A |
| 2020 | $77.14 Million | $223.01 Million | -$404.03 Million | 0.35x | N/A |
| 2021 | $56.31 Million | $485.63 Million | -$271.43 Million | 0.12x | N/A |
| 2022 | $46.17 Million | $472.08 Million | -$489.66 Million | 0.10x | N/A |
| 2023 | $30.97 Million | $537.40 Million | -$297.66 Million | 0.06x | N/A |
| 2024 | $15.15 Million | $383.96 Million | -$308.24 Million | 0.04x | N/A |
| 2025 | $10.87 Million | $460.51 Million | -$92.81 Million | 0.02x | N/A |
Competitor Companies of CCM by Market Capitalization
Companies near Concord Medical Services Holdings in the global market cap rankings as of August 6, 2026.
Key companies related to Concord Medical Services Holdings by market ranking:
- HCA Healthcare, Inc. (NYSE:HCA): Ranked #328 globally with a market cap of $80.16 Billion USD.
- Fresenius SE & Co. KGaA (XETRA:FRE): Ranked #913 globally with a market cap of $29.19 Billion USD ( €24.97 Billion EUR).
- FRESENIUS SE+CO. ADR 1/4 (F:FREA): Ranked #995 globally with a market cap of $26.87 Billion USD ( €22.98 Billion EUR).
- IHH Healthcare Bhd (KLSE:5225): Ranked #1382 globally with a market cap of $18.46 Billion USD ( RM73.52 Billion MYR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #328 | HCA Healthcare, Inc. | NYSE:HCA | $80.16 Billion | $409.64 |
| #913 | Fresenius SE & Co. KGaA | XETRA:FRE | $29.19 Billion | €46.65 |
| #995 | FRESENIUS SE+CO. ADR 1/4 | F:FREA | $26.87 Billion | €10.20 |
| #1382 | IHH Healthcare Bhd | KLSE:5225 | $18.46 Billion | RM8.32 |
Concord Medical Services Holdings Historical Marketcap From 2015 to 2026
Between 2015 and today, Concord Medical Services Holdings's market cap moved from $136.27 Million to $ 13.68 Million, with a yearly change of -18.34%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $13.68 Million | +25.91% |
| 2025 | $10.87 Million | -28.25% |
| 2024 | $15.15 Million | -51.09% |
| 2023 | $30.97 Million | -32.93% |
| 2022 | $46.17 Million | -18.00% |
| 2021 | $56.31 Million | -27.01% |
| 2020 | $77.14 Million | +2.62% |
| 2019 | $75.17 Million | -25.00% |
| 2018 | $100.23 Million | +6.91% |
| 2017 | $93.75 Million | -27.61% |
| 2016 | $129.51 Million | -4.96% |
| 2015 | $136.27 Million | -- |
End of Day Market Cap According to Different Sources
On Aug 6th, 2026 the market cap of Concord Medical Services Holdings was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $13.68 Million USD |
| MoneyControl | $13.68 Million USD |
| MarketWatch | $13.68 Million USD |
| marketcap.company | $13.68 Million USD |
| Reuters | $13.68 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Concord Medical Services Holdings
Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. It operates in two segments, Network and Hospital. The company's services include linear accelerators and external beam radiotherapy, proton therapy system, gamma knife radiosurgery, and diagnostic imaging services. Its other tre… Read more